SUAREZ CUENCA, JUAN ANTONIO

SUAREZ CUENCA, JUAN ANTONIO

CIENCIAS MÉDICAS · Nivel 2

Desde 2012 es Researcher en Centro Médico Nacional 20 de Noviembre

Información*

Nombre JUAN ANTONIO SUAREZ CUENCA
Área MEDICINA Y CIENCIAS DE LA SALUD
Campo CIENCIAS MÉDICAS
Disciplina INVESTIGACIÓN CLÍNICA
Especialidad GASTROENTEROLOGIA
CVU 36854
Institución
Dependencia CENTRO MEDICO NACIONAL 20 DE NOVIEMBRE
Entidad CIUDAD DE MEXICO
Nivel 2
Vigencia Inicio: 01/01/2025
Fin: 31/12/2029

* Información del primer trimestre de 2026.
Fuente: SECIHTI.

Publicaciones ORCID

2026
Gaze-Tracking-Based Tests for Autism in Children: A Diagnostic Test Accuracy Systematic Review and Meta-Analysis Autism
Gene expression in visceral adipocytes in metabolically healthy and unhealthy obesity: A cross-sectional analysis of associations with cardiometabolic components Science Progress
Association of Sarcopenia with Lower Adiponectin Levels and Reduced Estimated Appendicular Lean Mass in Patients with Metabolic Syndrome: A Cross-Sectional Study Diseases
2025
Mycobacterium tuberculosis Infects Human Visceral White Adipocytes and Expresses Dormancy Genes and Inflammatory Cytokines: The Role of Visceral Adipocytes in Latent Tuberculosis Infection International Journal of Molecular Sciences
Tomographic features of lung damage associate with D-Dimer levels and further clinical outcome in patients with acute respiratory distress syndrome due to COVID-19 BMC Pulmonary Medicine
2023
Nonalcoholic Fatty Liver Disease Severity Is Related to Plasma Pro-Oxidative Biomarkers Rather Than Liver Tissue-Measured Nitrogen Metabolism Biomarkers in Population with Obesity and Metabolic Syndrome Metabolic Syndrome and Related Disorders
NAMPT INHIBITION AND INCREASED NAD-BIOAVAILABILITY ATENUATE LIVER DAMAGE IN CCl4-INDUCED MICE LIVER FIBROSIS
2022
The metabolic phenotype of the patient influences the reduction in carotid intima-media thickness achieved following metabolic surgery Journal of International Medical Research
2021
Urine transferrin as an early endothelial dysfunction marker in type 2 diabetic patients without nephropathy: a case control study Diabetology & Metabolic Syndrome
Urine Transferrin as an Early Endothelial Dysfunction Marker in Type 2 Diabetic Patients Without Nephropathy: A Case Control Study.